Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data

Published:2024-02-26 Issue:1 Volume:20 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

van den Ouweland Frank¹,Charpentier Nicola²,Türeci Özlem³,Rizzi Ruben⁴,Mensa Federico J.⁵,Lindemann Claudia⁶,Pather Shanti⁷

Affiliation:

1. Medical Safety and Pharmacovigilance, BioNTech, Mainz, Germany

2. Risk Management, BioNTech, Mainz, Germany

3. BioNTech, Mainz, Germany

4. Global Regulatory Affairs, BioNTech, Germany, Germany

5. Clinical Development, Infectious Diseases, BioNTech, Mainz, Germany

6. Non-Clinical Safety, BioNTech, Mainz, Germany

7. Global Medical Affairs, BioNTech, Mainz, Germany

Funder

BioNTech

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2024.2315659

Reference101 articles.

1. Addressing COVID-19 vaccine hesitancy

2. Clinical development and approval of COVID-19 vaccines

3. Rolling Reviews During COVID-19: The European Union Experience in a Global Context

4. Vaccine Research and Development. [Internet]. Johns Hopkins University & Medicine; 2023 [accessed 2023 Mar 3]. https://coronavirus.jhu.edu/vaccines/timeline.

5. Emergency use authorization for vaccines to prevent COVID-19: guidance for industry. [Internet]. US Food And Drug Administration; 2022 [accessed 2022 Jul 12]. https://www.fda.gov/media/142749/download.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP